1. Home
  2. UFG vs SNTI Comparison

UFG vs SNTI Comparison

Compare UFG & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.67

Market Cap

29.7M

Sector

Energy

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.95

Market Cap

29.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
SNTI
Founded
2021
2016
Country
Singapore
United States
Employees
17
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
29.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UFG
SNTI
Price
$0.67
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
153.0K
181.8K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.77
52 Week High
$9.91
$3.88

Technical Indicators

Market Signals
Indicator
UFG
SNTI
Relative Strength Index (RSI) 36.24 47.55
Support Level $0.63 $0.86
Resistance Level $1.02 $1.02
Average True Range (ATR) 0.06 0.07
MACD -0.01 -0.00
Stochastic Oscillator 26.52 40.88

Price Performance

Historical Comparison
UFG
SNTI

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: